Specialty Pharmacy, Payer Goals in Atopic Dermatitis Management

2017-01-06 19:25:00
Tags: Atopic Dermatitis,Crisaborole,pediatric eczema,psoriasis,severe Atopic Dermatitis,specialty pharmacy,Ustekinumab,specialty pharmacy

Peter L. Salgo, MD; Ed Pezalla, MD, MPH; Cheryl Allen, BS Pharm, MBA; Jeffrey D. Dunn, Pharm D, MBA; and Jonathan Silverberg, MD, PhD, MPH, provide insight on specialty pharmacy and payer goals in the management of atopic dermatitis.